ZEB2 is an established regulator of EMT and has been linked to increased invasiveness and migration, poor prognosis for glioma patients, and is upregulated in glioblastoma and in DIPG as demonstrated in this study [36, 37, 68]. This evidence concerns the gene ZEB2 and diffuse intrinsic pontine glioma.